Author:
Ariazi Eric A.,Jordan V. Craig
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design and optimization of oestrogen receptor PROTACs based on 4-hydroxytamoxifen;European Journal of Medicinal Chemistry;2022-12
2. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design;Expert Opinion on Drug Discovery;2021-04-28
3. Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha;Bioorganic & Medicinal Chemistry Letters;2019-04
4. Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat;ACS Medicinal Chemistry Letters;2015-12-23
5. Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist;Journal of Medicinal Chemistry;2015-10-07